Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-03-28

Clinical Trial Update: Effects of Gene Polymorphisms on Metabolic Features in Clozapine-treated Patients With Schizophrenia

View source ↗

Summary

Clinical trial update examining how gene polymorphisms affect metabolic features in clozapine-treated patients with schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clozapine (Clozapine)

Snippet

Sponsor: Taipei Medical University WanFang Hospital | Conditions: Schizophrenia, Schizoaffective Disorder | Status: UNKNOWN